# Hynts Tech Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hynts-tech

- Industry: Biotechnology
- Headquarters: Kitakyushu-shi, Japan
- Website: www.hyntstech.com
- Latest round: Seed (Nov 18, 2025)
- Investors on record: 4

## About

Based in Japan, Hynts Tech Corporation specializes in advanced life sciences solutions, focusing on innovative products that enhance cellular manipulation and analysis.Hynts Tech Corporation, founded in 2021, operates from Kitakyushu-shi, Japan, providing advanced life sciences solutions. The company has completed 2 deals, with the most recent being on November 18, 2025. It does not have known subsidiaries or a parent company.Hynts Tech Corporation specializes in advanced life sciences solutions through its product, the NanoTube Membrane Stamp (NTs membrane stamp). This device employs nanotechnology to efficiently inject and extract substances from live cells, compatible with diverse microscope systems to ensure precise cell manipulation while preserving cell viability. The company caters to academic research institutions, biotechnology firms, and pharmaceutical companies across North America and Europe, facilitating applications in drug delivery, genetic engineering, and cellular analysis.Hynts Tech Corporation generates revenue from sales of its NTs membrane stamp and related cell processing services, with transactions occurring directly with clients such as research institutions and life sciences companies. Sales involve product kits containing multiple NTs membrane stamps and custom manufacturing services tailored to specific microscope compatibility, reflecting the advanced technology of its offerings.In November 2025, Hynts Tech Corporation raised an undisclosed amount in Seed funding from investors including basepartners, GxPartners, KYUTEC, 9Capital, and Spurcle. This funding will enhance the development of its cell processing technology and expedite product deployment to clients. The company aims to design and launch new products that expand its offerings and plans to enter new markets, specifically targeting regions in Asia and Europe by 2026.

## Funding rounds

- Seed, Nov 18, 2025 — Spurcle, GxPartners, basepartners, 9Capital

## Investors

- Spurcle (https://capitalatlas.ai/funds/spurcle) — Seed
- GxPartners (https://capitalatlas.ai/funds/gxpartners) — Seed
- basepartners (https://capitalatlas.ai/funds/basepartners) — Seed
- 9Capital (https://capitalatlas.ai/funds/9capital) — Seed